← ANALYSTS · TIPRANKS
Brian Skorney · Robert W. Baird
Hits
37%
178 of 478 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−5.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
18
Buy / hold / sell: 13 / 3 / 2
Upside of the analyst’s targets
+80.2%
Average over 18 current targets, to the last price
The market’s answer to the ratings
+2.7%
Day-0 move against SPY in the rating’s direction, average over 18 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 13on TipRanks 07:15 | NRIXIWMNurix Therapeutics · $2.7B | Reiterated | Buy | $33.00 → $36.00+9.1% | +47.4% | −0.1%next day +8.0% | ↗ |
| Oct 2on TipRanks 09:15 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Hold | $761 | −3.8% | −0.7%next day −1.9% · 5 days +0.4% | ↗ |
| Sep 29on TipRanks 07:30 | MIRMIWMMirum Pharmaceuticals · $5.3B | Reiterated | Buy | $123 → $130+5.7% | +62.2% | −0.3%next day −2.1% · 5 days −11.4% | ↗ |
| Sep 18on TipRanks 07:15 | XENEIWMXenon · $3.3B | Reiterated | Buy | $97.00 → $90.00−7.2% | +168.7% | −30.8%next day −3.5% · 5 days −8.3% | ↗ |
| Sep 9on TipRanks 07:08 | DYNIWMDyne Therapeutics · $2.9B | Reiterated | Buy | $30.00 → $26.00−13.3% | +82.5% | −5.0%next day −3.4% · 5 days −8.7% | ↗ |
| Sep 3on TipRanks 12:55 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | $21.00 → $25.00+19.0% | +154.6% | −4.1%next day +6.8% · 5 days −1.2% | ↗ |
| Sep 1on TipRanks 15:30 | ALMSIWMAlumis Inc. · $842M | Reiterated | Buy | $35.00 → $27.00−22.9% | +341.2% | −55.9%next day +8.8% · 5 days +3.4% | ↗ |
| Aug 25on TipRanks 06:30 | RGNXIWMRegenXBio · $473M | Reiterated | Buy | $32.00 → $29.00−9.4% | +318.8% | +10.3%next day +5.3% · 5 days +5.1% | ↗ |
| Aug 7on TipRanks 08:10 | PRAXIWMPraxis Precision Medicines · $6.9B | Reiterated | Buy | $400 → $514+28.5% | +112.6% | −3.1%next day +1.7% · 5 days +1.3% | ↗ |
| Aug 5on TipRanks 07:35 | AMGNQQQSPYAmgen · $235B | Reiterated | Sell | $215 → $230+7.0% | −46.8% | +4.8%next day −0.6% · 5 days +1.7% | ↗ |
| Aug 4on TipRanks 06:45 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $252 → $280+11.1% | +33.2% | +2.2%next day +0.2% · 5 days −5.1% | ↗ |
| Jul 31on TipRanks 07:33 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Hold | $742 → $761+2.6% | −3.8% | +2.6%next day −1.9% · 5 days −0.7% | ↗ |
| Jul 31on TipRanks 07:26 | NBIXNeurocrine · $13.9B | Reiterated | Buy | $186 → $225+21.0% | +65.8% | −10.8%next day −1.8% · 5 days −5.5% | ↗ |
| Jul 7on TipRanks 07:00 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Reiterated | Sell | $330 → $350+6.1% | −30.0% | −0.9%next day −4.3% · 5 days −9.3% | ↗ |
| May 18on TipRanks 07:40 | ANROIWMAlto Neuroscience, Inc. · $888M | Reiterated | Buy | $38.00 → $36.00−5.3% | +64.1% | −5.1%next day −5.5% · 5 days −5.0% | ↗ |
| May 5on TipRanks 06:35 | AXSMAxsome Therapeutics · $8.2B | Reiterated | Buy | $241 → $246+2.1% | +56.5% | −1.1%next day −1.6% · 5 days −1.6% | ↗ |
| Feb 26on TipRanks 10:26 | SRPTIWMSarepta Therapeutics · $1.9B | Reiterated | Hold | $22.00 → $20.00−9.1% | +17.0% | −7.5%next day −3.5% · 5 days −5.8% | ↗ |
| Feb 11on TipRanks 07:38 | GILDQQQSPYGilead Sciences · $195B | Reiterated | Hold | $108 → $145+34.3% | −7.2% | +5.8%next day −1.0% · 5 days −1.9% | ↗ |
| Oct 31on TipRanks 09:45 | BIIBSPYBiogen · $34.8B | Reiterated | Buy | $255 → $250−2.0% | +7.5% | +2.8%next day −2.0% · 5 days +2.4% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗